Drawing for CETSA

USPTO serial 79173127

CETSA

Reviewed by CopyMark Law Group

Reg. 4948669Status 707Registered
Filing date
Status date
Registration date
May 3, 2016
Examiner
POLZER, NATALIE M
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with CETSA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Garth M. Dahlen

Garth M. Dahlen MENDELSOHN DUNLEAVY P.C.Two Penn Center, Suite 9101500 John F. Kennedy Blvd.Philadelphia, PA 19102

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical preparations for use in science * other than for medical or veterinary use; * biochemicals for in vitro and in vivo [ for ] scientific use; biological tissue cultures other than for medical or veterinary purposes; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents scientific use; antibodies for in vitro research use; antibodies for in vitro scientific use; reagents for scientific purposes; [ chemical ] substances, namely, chemicals for scientific laboratory use; testing reagents for scientific use; universal reagents for automated test systems for scientific or laboratory research use; universal reagents for automated test systems for scientific use; [ chemical ] substances, namely, chemicals for scientific use; enzymes for scientific purposes; enzymes, other than for medical use, used in detecting proteins; proteins in raw material form for use in science; protein in raw material form for scientific and medical research; chemical substances, namely, chemicals for impregnation into membranes to separate proteins from liquids ]SECTION 71 - CANCELLED—
005[ Diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic testing materials, namely, agents, preparations and substances for medical use; diagnostic reagents for medical use; diagnostic indicators, namely, protein arrays for medical diagnosis; chemical reagents for medical or veterinary purposes; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes chemical test reagents veterinary; reagents for medical analytical purposes; reagents for use in medical analysis; reagents for medical in-vitro laboratory use ]SECTION 71 - CANCELLED—
042Services of a chemical and/or biological laboratory; scientific research and development services; laboratory testing; laboratory services; testing of pharmaceuticals; analysis of human tissues for medical research; research on the subject of pharmaceuticals; research and development of vaccines and medicines; conducting early evaluations in the field of new pharmaceuticals; medical research; medical research laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; biochemical research and development; biochemical analysis; biochemistry research services; biological analysis; biomedical research services; chemical research and analysis servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 12, 202671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Aug 10, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 1, 2026ES71TEAS SECTION 71 RECEIVED—
Nov 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 3, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jan 16, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Jul 10, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
May 26, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 26, 2023INPCINVALIDATION PROCESSED—
May 1, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 1, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Sep 1, 2022C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Aug 30, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 19, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 22, 2022ES75TEAS SECTION 71 & 15 RECEIVED—
May 3, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 28, 2017INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jan 26, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 26, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 4, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 4, 2016FIMPFINAL DISPOSITION PROCESSED—
Aug 3, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 27, 2016LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
May 26, 2016COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 26, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 19, 2016LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 3, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 16, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 13, 2016GPNXNOTIFICATION PROCESSED BY IB—
Jan 27, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 27, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 11, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 4, 2016ALIEASSIGNED TO LIE—
Dec 29, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 2, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 2, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2015ALIEASSIGNED TO LIE—
Nov 9, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2015RFNTREFUSAL PROCESSED BY IB—
Nov 2, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 16, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 16, 2015RFRRREFUSAL PROCESSED BY MPU—
Oct 10, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 9, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 2, 2015DOCKASSIGNED TO EXAMINER—
Oct 2, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 1, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance